Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 11 to 20 of 24

TitleReference numberPublishedLast updated
Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years (terminated appraisal)TA1135
Type 2 diabetes in adultsQS209
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2HST34
Belantamab mafodotin with pomalidomide and dexamethasone for previously treated multiple myelomaTA1133
Dupilumab for treating severe chronic rhinosinusitis with nasal polypsTA1134
Type 2 diabetes in adults: managementNG28
Ruxolitinib for treating moderate to severe chronic graft versus host disease after an allogeneic stem cell transplant in people 28 days to 17 years (terminated appraisal)TA1132
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA1129
Obinutuzumab with mycophenolate mofetil for treating lupus nephritisTA1131
Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancerTA1130

Results per page

  1. 10
  2. 25
  3. 50
  4. All